ScoreWhy is Kidswell Bio Corp. ?
1
Poor Management Efficiency with a low ROCE of 2.20%
- The company has been able to generate a Return on Capital Employed (avg) of 2.20% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -34.17
- Poor long term growth as Operating profit has grown by an annual rate 17.97% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -34.17
- The company has been able to generate a Return on Capital Employed (avg) of 2.20% signifying low profitability per unit of total capital (equity and debt)
3
Poor long term growth as Operating profit has grown by an annual rate 17.97% of over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
- NET PROFIT(HY) At JPY -63.04 MM has Grown at -118.3%
- NET SALES(Q) Lowest at JPY 1,269.51 MM
- INTEREST(Q) Highest at JPY 23.06 MM
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -38.38%, its profits have risen by 103.8% ; the PEG ratio of the company is 1.9
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Kidswell Bio Corp. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Kidswell Bio Corp.
-38.75%
0.49
56.23%
Japan Nikkei 225
43.58%
1.48
29.43%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
45.98%
EBIT Growth (5y)
17.97%
EBIT to Interest (avg)
-20.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
1.32
Tax Ratio
2.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.20%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
193
Industry P/E
Price to Book Value
3.40
EV to EBIT
21.57
EV to EBITDA
21.52
EV to Capital Employed
7.04
EV to Sales
0.76
PEG Ratio
1.87
Dividend Yield
NA
ROCE (Latest)
32.61%
ROE (Latest)
1.76%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 6.51 times
CASH AND EQV(HY)
Highest at JPY 6,528.45 MM
OPERATING PROFIT(Q)
Highest at JPY 216.54 MM
OPERATING PROFIT MARGIN(Q)
Highest at 17.06 %
PRE-TAX PROFIT(Q)
Highest at JPY 204.31 MM
NET PROFIT(Q)
Highest at JPY 170.58 MM
EPS(Q)
Highest at JPY 3.9
-27What is not working for the Company
NET PROFIT(HY)
At JPY -63.04 MM has Grown at -118.3%
NET SALES(Q)
Lowest at JPY 1,269.51 MM
INTEREST(Q)
Highest at JPY 23.06 MM
Here's what is working for Kidswell Bio Corp.
Pre-Tax Profit
At JPY 204.31 MM has Grown at 317.37%
over average net sales of the previous four periods of JPY -93.99 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 170.58 MM has Grown at 276.29%
over average net sales of the previous four periods of JPY -96.76 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Inventory Turnover Ratio
Highest at 6.51 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Profit
Highest at JPY 216.54 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 17.06 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 204.31 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY 170.58 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 3.9
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Cash and Eqv
Highest at JPY 6,528.45 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Kidswell Bio Corp.
Net Sales
At JPY 1,269.51 MM has Fallen at -22.94%
over average net sales of the previous four periods of JPY 1,647.48 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (JPY MM)
Net Sales
Lowest at JPY 1,269.51 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (JPY MM)
Interest
Highest at JPY 23.06 MM
in the last five periods and Increased by 9.36% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Footer loading
